MedPath

Study on the Ability of Virtual Reality Glasses in Anxiety and Pain Reduction in 50 Women Undergoing Amniocentesis or Feticide

Not Applicable
Conditions
Amniocentesis
Anxiety Acute
Foeticide
Registration Number
NCT04491149
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

Both amniocenteses and especially feticide are procedures that incorporate both anxiety and pain. As anxiety and pain can be reduced when using a distraction, The investigators speculate that the use of virtual reality glasses during these procedures will elevate both anxiety and pain.

The investigators will examine this hypothesis by comparing two groups of participants who undergo amniocentesis or feticide, one group will undergo the procedure while using virtual reality glasses and the other without the use of the glasses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria

Pregnant women undergoing amniocentesis/foeticide who will sign an informed consent form

Exclusion Criteria
  • Women younger than 18 years
  • Twin pregnancies
  • Women with vertigo

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Anxiety levelUp to one hour after the procedure

Spielberger's State-Trait Anxiety Inventory

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asaf ha Rofeh, MC

🇮🇱

Zrifin, Israel

Asaf ha Rofeh, MC
🇮🇱Zrifin, Israel
Ran Svirsky, Doctor of Medicine
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.